BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 29686678)

  • 1. Immunoglobulin E-Mediated Autoimmunity.
    Maurer M; Altrichter S; Schmetzer O; Scheffel J; Church MK; Metz M
    Front Immunol; 2018; 9():689. PubMed ID: 29686678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of IgE in autoimmunity.
    Sanjuan MA; Sagar D; Kolbeck R
    J Allergy Clin Immunol; 2016 Jun; 137(6):1651-1661. PubMed ID: 27264000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
    van Beek N; Schulze FS; Zillikens D; Schmidt E
    Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses.
    Ettinger R; Karnell JL; Henault J; Panda SK; Riggs JM; Kolbeck R; Sanjuan MA
    Autoimmunity; 2017 Feb; 50(1):25-36. PubMed ID: 28166684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?
    Ujiie H
    J Dermatol Sci; 2015 Apr; 78(1):5-10. PubMed ID: 25797172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring mechanisms of IgE-mediated autoimmunity through the lens of bullous pemphigoid.
    Messingham KN; Randall G; Fairley J
    G Ital Dermatol Venereol; 2016 Apr; 151(2):186-97. PubMed ID: 26959553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid.
    Hashimoto T; Ohzono A; Teye K; Numata S; Hiroyasu S; Tsuruta D; Hachiya T; Kuroda K; Hashiguchi M; Kawakami T; Ishii N
    Br J Dermatol; 2017 Jul; 177(1):141-151. PubMed ID: 27716903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
    Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z
    Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE blockade in autoimmunity: Omalizumab induced remission of bullous pemphigoid.
    James T; Salman S; Stevenson B; Bundell C; Kelly G; Nolan D; John M
    Clin Immunol; 2019 Jan; 198():54-56. PubMed ID: 30557620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
    van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E
    JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of IgE in bullous pemphigoid: a review and rationale for IgE directed therapies.
    Messingham KN; Pietras TA; Fairley JA
    G Ital Dermatol Venereol; 2012 Jun; 147(3):251-7. PubMed ID: 22648326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice.
    Fairley JA; Burnett CT; Fu CL; Larson DL; Fleming MG; Giudice GJ
    J Invest Dermatol; 2007 Nov; 127(11):2605-11. PubMed ID: 17611576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
    Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
    J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Most Patients With Autoimmune Chronic Spontaneous Urticaria Also Have Autoallergic Urticaria, but Not ViceVersa.
    Xiang YK; Kolkhir P; Scheffel J; Sauer M; Vera C; Frischbutter S; Krause K; Siebenhaar F; Metz M; Maurer M; Altrichter S
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2417-2425.e1. PubMed ID: 36805105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid.
    Fairley JA; Fu CL; Giudice GJ
    J Invest Dermatol; 2005 Sep; 125(3):467-72. PubMed ID: 16117787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoreactive T cells and their role in atopic dermatitis.
    De Bruyn Carlier T; Badloe FMS; Ring J; Gutermuth J; Kortekaas Krohn I
    J Autoimmun; 2021 Jun; 120():102634. PubMed ID: 33892348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review.
    Saniklidou AH; Tighe PJ; Fairclough LC; Todd I
    Arch Dermatol Res; 2018 Jan; 310(1):11-28. PubMed ID: 29071428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review.
    Kolkhir P; Metz M; Altrichter S; Maurer M
    Allergy; 2017 Oct; 72(10):1440-1460. PubMed ID: 28407273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid.
    Dimson OG; Giudice GJ; Fu CL; Van den Bergh F; Warren SJ; Janson MM; Fairley JA
    J Invest Dermatol; 2003 May; 120(5):784-8. PubMed ID: 12713582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.